Literature DB >> 20846917

LC-MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma.

Oskar Gonzalez1, Gorka Iriarte, Estitxu Rico, Nerea Ferreirós, Miren Itxaso Maguregui, Rosa Maria Alonso, Rosa Maria Jiménez.   

Abstract

A simple, fast and validated method is reported for the simultaneous analysis, in human plasma, of several drugs usually combined in cardiovascular therapy (atenolol, bisoprolol, hydrochlorothiazide, chlorthalidone, salicylic acid, enalapril and its active metabolite enalaprilat, valsartan and fluvastatin) using high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) with electrospray ionization (ESI), working in multiple reaction monitoring mode (MRM). Separation of analytes and internal standard (pravastatin) was performed on a Luna C18(2) (150mm×4.6mm, 3μm) column using a gradient elution mode with a run time of 15min. The mobile phase consisted of a mixture of acetonitrile and water containing 0.01% formic acid and 10mM ammonium formate at pH 4.1. Sample treatment consisted of a simple protein precipitation with acetonitrile, enabling a fast analysis. The method showed good linearity, precision (RSD% values between 0.7% and 12.7%) and accuracy (relative error values between 0.9% and 14.0%). Recoveries were within 68-106% range and the ion-suppression was not higher than 22% for any analyte. The method was successfully applied to plasma samples obtained from patients under combined cardiovascular treatment.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846917     DOI: 10.1016/j.jchromb.2010.07.026

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

1.  An LC-MS assay for the screening of cardiovascular medications in human samples.

Authors:  Eduardo Dias; Brian Hachey; Candace McNaughton; Hui Nian; Chang Yu; Brittany Straka; Nancy J Brown; Richard M Caprioli
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-08-16       Impact factor: 3.205

2.  Importance of thorough investigation of resistant hypertension before renal denervation: should compliance to treatment be evaluated systematically?

Authors:  J Rosa; T Zelinka; O Petrák; B Štrauch; Z Šomlóová; T Indra; R Holaj; K Čurila; P Toušek; M Šenitko; P Widimský; J Widimský
Journal:  J Hum Hypertens       Date:  2014-02-06       Impact factor: 3.012

3.  Tailored Assays for Pharmacokinetic and Pharmacodynamic Investigations of Aliskiren and Enalapril in Children: An Application in Serum, Urine, and Saliva.

Authors:  Bjoern B Burckhardt; Jutta Tins; Sergej Ramusovic; Stephanie Läer
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Nov-Dec

4.  Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers.

Authors:  Abdel-Rahim M El-Helw; Usama A Fahmy
Journal:  Int J Nanomedicine       Date:  2015-09-16

5.  Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin.

Authors:  Jun Li; Min Yang; Wen-Rong Xu
Journal:  Drug Des Devel Ther       Date:  2018-10-23       Impact factor: 4.162

6.  Transdermal delivery of fluvastatin sodium via tailored spanlastic nanovesicles: mitigated Freund's adjuvant-induced rheumatoid arthritis in rats through suppressing p38 MAPK signaling pathway.

Authors:  Shahira F El Menshawe; Mohamed M Nafady; Heba M Aboud; Rasha M Kharshoum; Asmaa Mohammed M Hussein Elkelawy; Doaa S Hamad
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

7.  Simultaneous Determination and Pharmacokinetic Study of Losartan, Losartan Carboxylic Acid, Ramipril, Ramiprilat, and Hydrochlorothiazide in Rat Plasma by a Liquid Chromatography/Tandem Mass Spectrometry Method.

Authors:  Ramkumar Dubey; Manik Ghosh
Journal:  Sci Pharm       Date:  2014-11-30

8.  Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells.

Authors:  Lamya H Al-Wahaibi; Muneera S M Al-Saleem; Osama A A Ahmed; Usama A Fahmy; Nabil A Alhakamy; Basma G Eid; Ashraf B Abdel-Naim; Wael M Abdel-Mageed; Maha M AlRasheed; Gamal A Shazly
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

9.  Simultaneous determination of cardiovascular drugs in dried blood spot by liquid chromatography-tandem mass spectrometry.

Authors:  Hyung Min Kim; Ju-Hwan Park; Nguyen Phuoc Long; Dae-Duk Kim; Sung Won Kwon
Journal:  J Food Drug Anal       Date:  2019-06-26       Impact factor: 6.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.